Aardvark Therapeutics Inc. Common Stock

AARD | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.57

+$0.19 (+3.53%)

At close: Sep 21, 2026, 4:00 PM ET

$5.56

-$0.01 (-0.18%)

After-hours: Sep 21, 2026, 7:54 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $121.89M

Enterprise Value $48.7M

Beta 3.74

Average Volume 225.64K

Shares Outstanding (Diluted) 21.85M

Shares Change YoY 0.71%

Institutional Ownership 46.75%

Exchange NASDAQ

ISIN US0029421007

Price Performance

Price Change 1M -17.5%

Price Change 3M 31.7%

Price Change 6M 57.3%

Price Change YTD -57.8%

Price Change 1Y -50.4%

Price Change 3Y -58.1%

Price Change 5Y -58.1%

1M CAGR (ann.) -29.5%

1Y CAGR (ann.) -50.7%

5Y CAGR (ann.) N/A

All-Time CAGR -44.5%

Valuation

PE Ratio -1.74

Forward PE N/A

PEG Ratio 0.03

Forward PEG 0.09

PS Ratio N/A

Forward PS 118.80

PB Ratio 1.63

P/FCF Ratio -1.76

P/Adj. FCF Ratio -1.66

P/OCF Ratio -1.75

EV/Sales N/A

EV/EBIT -0.70

EV/EBITDA -0.70

EV/FCF -0.70

Earnings Yield -57.6%

FCF Yield -56.9%

Adj. FCF Yield -60.2%

Financial Health

Net Cash $73.19M

Total Debt $677K

Cash & Short-Term Investments $73.87M

Total Assets $81.46M

Current Ratio 12.63

Quick Ratio 12.63

Debt / Equity Ratio 0.01

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -102.52

Interest Coverage 0.00

Altman Z-Score 6.63

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -5.7%

Returns

Return on Assets -85.8%

Return on Equity -71.5%

Return on Invested Capital -98.0%

Return on Capital Employed -98.5%

Return on Tangible Assets -85.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -87.8%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -92.8%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 9

EPS Growth Next 3Y 17.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.74

EPS Growth Est (next Q) -1.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $3

Price Target Upside -46.1%

Cash Flow

Operating Cash Flow $-69.41M

Free Cash Flow $-69.41M

Adj. Free Cash Flow $-73.37M

FCF Per Share -$3.18

OCF Per Share -$3.18

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-73.96M

EBITDA $-69.86M

Net Income $-69.89M

EPS (Diluted) -$3.21

Revenue / Employee N/A

Profit / Employee $-2.5M

Employees 28